Novartis settles one of two MS drug patent disputes
Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case
Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case
Job losses form part of global restructuring
Viatris generic medicines facility in Baldoyle due to shut down over next two years
Merged entity becomes largest player in global generic pharmaceuticals market
Stoxx 600 weighed down by Wirecard over missing $2.1bn in payments firm’s accounts
Generics group ramps up production of old malaria drug, named by Trump as Covid-19 therapy
Pharma and IT sectors need more staff due to drug development and remote working
Keytruda parent lowers full-year forecasts while Pfizer expects recovery in second half of year
New stockpile will be available to Member States fighting impact of coronavirus
Supplies and health pose risks parallel to Brexit and require new financial forecasts
Salesforce, Glanbia and CRH to report; Guaranteed Irish roadshow on future trends takes place in UCC
Drug giant warns managing costs in Ireland remains a ‘significant business challenge’
Darina Allen talks to women who don’t lunch, while the FT’s Martin Wolf talks transformation
Pharma company delivers rosier guidance as it focuses on branded drugs
Markets report: Aryzta continues slide in Dublin; Bank of Ireland, Ryanair fall
Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn
Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland
Markets report: Airbus rises after strong delivery numbers, Superdry slumps to a loss
Dalata and Ryanair both lost ground, while Irish banking stocks were in favour
Ibec to host its European election debates and IFG shareholders vote on takeover
Shares in British maker of opioid addiction treatment Suboxone fell more than 70%
This Week: Big week for banks as SME lending stays weak amid Brexit caution
Lobbyists call for extending use of cheaper ‘copycat’ drugs where available
National Analytics Conference takes place in Dublin, results due from Liberty Media
Policy of switching to biosimilar drugs never adopted
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Company plans to introduce generic version of Humira either later this year or early in 2019
Markets report: Iseq down almost 0.8% as Aryzta hits fresh low
Generic drugs giant falls far short of Wall Street forecasts with second-quarter profit
Figures for car sales in July to give pointer to performance for remainder of year
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Drugmaker says approving more biosimilar drugs for use here could save the State €140m a year
The public can’t continue to pay for the inaction of policymakers
Biopharma firm Gilead unsuccessful in patent row over its pre-exposure prophylaxis drug
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices